Skip to content
PoliTrackerPrototype - alpha version 0.1
← Policies

Proposed

Bill · 119th Congress · HR 1060

Modern Authentication of Pharmaceuticals Act of 2025

Refreshed 5 h ago

Introduced 2025-02-06Topic: health care

Summary

Summary by the Congressional Research Service

Modern Authentication of Pharmaceuticals Act of 2025 This bill requires each dose of a pharmaceutical product that is a controlled substance and that is taken orally in solid form (i.e., pills) to include a physical chemical identifier. (Physical chemical identifiers are substances that possess a unique physical or chemical property, such as inks, pigments, flavors, and molecular taggants, that unequivocally identify and authenticate a drug or dosage.) Under the bill, physical chemical identifiers must be included in or on the product and must be machine readable. The bill applies to products manufactured beginning five years after the bill's enactment.

Full text and official record on Congress.gov

Sponsors

Action history

DateChamberActionStatus effect
2025-02-06HouseReferred to the House Committee on Energy and Commerce.refer
2025-02-06Introduced in Houseintroduce
2025-02-06Sponsor introductory remarks on measure. (CR H519)
2025-02-06Introduced in Houseintroduce
Source: GovInfo Bill Status (Library of Congress), fetched 2026-09-11. Provisions and opinion polling arrive in a later release.